5 – Amino – 1MQ

Price range: $49.99 through $415.00

Earn up to 415 Points.
-
+

5-Amino-1-methylquinolinium (commonly known as 5-Amino-1-MQ) is a small molecule that functions as a selective, membrane-permeable inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT) (Neelakantan et al., 2018). While often categorized as a “peptide” in fitness and biohacking communities, it is chemically a methylquinolinium derivative rather than a chain of amino acids.

The primary interest in 5-Amino-1-MQ stems from its ability to manipulate cellular energy metabolism, particularly in fat and muscle tissues.

Core Mechanisms & Metabolic Benefits

Research indicates that inhibiting NNMT with 5-Amino-1-MQ can reverse diet-induced obesity and improve metabolic health through several pathways:

  • Reduction in Adiposity: In preclinical studies, treatment with 5-Amino-1-MQ significantly reduced body weight and white adipose (fat) mass in obese mice (Neelakantan et al., 2018). It achieves this by decreasing the size of adipocytes and suppressing lipogenesis (the creation of new fat) (Neelakantan et al., 2018; Sun et al., 2024).
  • Increased NAD+ Levels: NNMT typically consumes nicotinamide, a precursor to NAD+. By inhibiting this enzyme, 5-Amino-1-MQ increases intracellular NAD+ and S-adenosyl-L-methionine (SAM) levels, which are critical for mitochondrial function and energy expenditure (Neelakantan et al., 2018; Sun et al., 2024).
  • Enhanced Insulin Sensitivity: NNMT inhibition has been linked to improved glucose tolerance and reduced insulin resistance in models of metabolic syndrome (Sun et al., 2024).
  • Muscle Maintenance: Unlike standard calorie restriction, which can lead to muscle loss, NNMT inhibitors are studied for their potential to promote a “negative energy balance” while supporting muscle cell viability (Neelakantan et al., 2018; Sun et al., 2024).

Research Reports & Data Summary

Metric Findings in Preclinical Models Source
Weight Loss Significant reduction in body weight and fat mass in high-fat diet models. Neelakantan et al. (2018)
Lipid Profile Lowered plasma total cholesterol levels. Neelakantan et al. (2018)
Selectivity High selectivity for NNMT; does not inhibit related methyltransferases or the NAD+ salvage pathway. Neelakantan et al. (2018)
Cellular Impact Increases UCP1-independent thermogenesis and fat oxidation. Sun et al. (2024)

Related products

Advanced Peptide Research


All products sold by APR Labs are for laboratory research use only. Not for human or animal consumption, injection, or medical use. APR Labs does not provide medical advice. By purchasing, you agree that you are a qualified professional and assume all responsibility for handling and use. See our Research Use Disclaimer for full terms.

You must be
21+ years old to access this website.

By clicking ENTER, you confirm that you are 21 or older and understand that all products sold by APR Labs are strictly for research purposes only and NOT for human or animal consumption, or for any medical or therapeutic use.You also agree to comply with all applicable laws and take full responsibility for proper handling and use.

If you do not agree, please click EXIT.